Delivery Order SPE2DB25D7068-SPE2DB25FTXEN
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,402.20. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement through open competition. The order is scheduled for ultimate completion by June 20, 2025, and will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $10,374.00 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets (300 count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, with a contract value of $1,085.95. This competitively awarded, non-set-aside delivery order carries a firm fixed price and an ultimate completion date of May 7, 2025. The contract is performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 500 units, with a contract ceiling value of $2,077.68. This is a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units. This competitively awarded, non-set-aside contract carries a ceiling value of $2,460.00 with firm fixed pricing and an ultimate completion date of July 24, 2025. The pharmaceutical products will be performed and delivered from the contractor's corporate office location in Conshohocken,...
- On July 21, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,268.75 to AmerisourceBergen Drug Corp for 1,000 tablets of Doxycycline Hyclate 100 mg. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 22, 2025. The contractor, headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location. This delivery order represents a routine...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, valued at $1,199.28 under a firm fixed price contract. This order represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The award was made through open...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Doxycycline Hyclate 100 mg, valued at $1,121.97, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order was issued on August 5, 2025, with no set-aside designation. The product will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,126.63 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units. This contract, issued on May 19, 2025, with an ultimate completion date of May 20, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award falls under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,488.09. This firm fixed price delivery order is non-set-aside and represents a straightforward pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTXENDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in a quantity of 1,000 units, valued at $1,565.14. This contract utilizes firm fixed pricing and carries an ultimate completion date of July 11, 2025. The award represents a non-set-aside, competitively awarded delivery order with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has established itself as a critical vendor for federal medical procurement through its extensive portfolio of pharmaceutical products and medical supplies. The company's comprehensive IDC with DLA enables it to supply a wide range of medications, vaccines, and specialized medical commodities to support military healthcare programs globally, including delivery to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The doxycycline hyclate delivery under this order represents a routine pharmaceutical supply fulfillment, consistent with the company's ongoing role in supporting Department of Defense medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/10/25 |